文献速递慢性肾脏病

缺氧诱导因子稳定化改善慢性肾脏病啮齿动物模型缺血诱导的血管新生障碍

Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
PubMed 文献 · Kidney Int · 2016-12-04

在5/6肾切除所致慢性肾脏病(CKD)大鼠后肢缺血模型中,缺血骨骼肌毛细血管密度及HIF及其促血管新生靶基因表达均显著低于假手术对照。一氧化碳和脯氨酰羟化酶抑制剂ICA两种HIF稳定化处理均能恢复CKD动物的HIF靶基因表达,并显著增加缺血诱导的毛细血管出芽,ICA在缺血前后给药均有效。

要点

  • CKD大鼠缺血骨骼肌毛细血管密度显著低于假手术对照。
  • CKD大鼠HIF及Vegf、Vegf-r1、Vegf-r2、Ho-1表达显著降低。
  • 一氧化碳和ICA均恢复HIF靶基因并增加毛细血管出芽,ICA缺血后给药亦有效。

核心结论

  • CKD大鼠缺血诱导的血管新生障碍可通过HIF稳定化改善,即使于缺血发生后开始给药亦有效。

研究设计与样本

  • 研究在5/6肾切除所致CKD大鼠中诱导后肢缺血,并给予一氧化碳或脯氨酰羟化酶抑制剂ICA两种HIF稳定化处理。
  • 采用qRT-PCR检测促血管新生HIF靶基因(Vegf、Vegf-r1、Vegf-r2、Ho-1)表达,CD31免疫荧光染色测毛细血管密度,免疫组化评估HIF表达。

主要发现

  • CKD动物缺血骨骼肌毛细血管密度显著低于假手术对照。
  • CKD大鼠HIF及所有检测的促血管新生HIF靶基因(包括VEGF)表达显著降低。
  • 两种HIF稳定化处理均恢复CKD动物的HIF靶基因表达,并使缺血诱导的毛细血管出芽显著高于未处理对照。
  • ICA在缺血诱导前或后给药均有效,并导致骨骼肌HIF表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic kidney disease (CKD) is associated with increased risk and worse prognosis of cardiovascular disease, including peripheral artery disease. An impaired angiogenic response to ischemia may contribute to poor outcomes of peripheral artery disease in patients with CKD. Hypoxia inducible factors (HIF) are master regulators of angiogenesis and therefore represent a promising target for therapeutic intervention. To test this we induced hind-limb ischemia in rats with CKD caused by 5/6 nephrectomy and administered two different treatments known to stabilize HIF protein in vivo: carbon monoxide and a pharmacological inhibitor of prolyl hydroxylation 2-(1-chloro-4- hydroxyisoquinoline-3-carboxamido) acetate (ICA). Expression levels of pro-angiogenic HIF target genes (Vegf, Vegf-r1, Vegf-r2, Ho-1) were measured by qRT-PCR. Capillary density was measured by CD31 immunofluorescence staining and HIF expression was evaluated by immunohistochemistry. Capillary density in ischemic skeletal muscle was significantly lower in CKD animals compared to sham controls. Rats with CKD showed significantly lower expression of HIF and all measured pro-angiogenic HIF target genes, including VEGF. Both HIF stabilizing treatments rescued HIF target gene expression in animals with CKD and led to significantly higher ischemia-induced capillary sprouting compared to untreated controls. ICA was effective regardless of whether it was administered before or after induction of ischemia and led to a HIF expression in skeletal muscle. Thus, impaired ischemia-induced angiogenesis in rats with CKD can be improved by HIF stabilization, even if started after onset of ischemia.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Schellinger IN, Cordasic N, Panesar J, et al. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease. Kidney Int. 2016. PMID: 27927598. doi:10.1016/j.kint.2016.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。